ABBVIE INC (1ABBV.MI) Fundamental Analysis & Valuation

BIT:1ABBV • US00287Y1091

Current stock price

182.8 EUR
+7.2 (+4.1%)
Last:

This 1ABBV.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. 1ABBV.MI Profitability Analysis

1.1 Basic Checks

  • 1ABBV had positive earnings in the past year.
  • 1ABBV had a positive operating cash flow in the past year.
  • Of the past 5 years 1ABBV 4 years were profitable.
  • 1ABBV had a positive operating cash flow in 4 of the past 5 years.
1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 1ABBV has a Return On Assets of 1.75%. This is in the better half of the industry: 1ABBV outperforms 71.25% of its industry peers.
  • 1ABBV's Return On Invested Capital of 15.64% is amongst the best of the industry. 1ABBV outperforms 93.75% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 11.89%.
  • The last Return On Invested Capital (15.64%) for 1ABBV is above the 3 year average (13.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROIC 15.64%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1ABBV.MI Yearly ROA, ROE, ROIC1ABBV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • With a decent Profit Margin value of 3.94%, 1ABBV is doing good in the industry, outperforming 73.75% of the companies in the same industry.
  • 1ABBV's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1ABBV (33.05%) is better than 86.25% of its industry peers.
  • 1ABBV's Operating Margin has declined in the last couple of years.
  • 1ABBV has a Gross Margin (71.16%) which is comparable to the rest of the industry.
  • 1ABBV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
1ABBV.MI Yearly Profit, Operating, Gross Margins1ABBV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 1ABBV.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ABBV is creating some value.
  • 1ABBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ABBV.MI Yearly Shares Outstanding1ABBV.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
1ABBV.MI Yearly Total Debt VS Total Assets1ABBV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 2.32 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 1ABBV's Altman-Z score of 2.32 is fine compared to the rest of the industry. 1ABBV outperforms 63.75% of its industry peers.
  • The Debt to FCF ratio of 1ABBV is 3.49, which is a good value as it means it would take 1ABBV, 3.49 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.49, 1ABBV belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Altman-Z 2.32
ROIC/WACC1.75
WACC8.96%
1ABBV.MI Yearly LT Debt VS Equity VS FCF1ABBV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

  • 1ABBV has a Current Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV has a worse Current ratio (0.72) than 76.25% of its industry peers.
  • 1ABBV has a Quick Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV's Quick ratio of 0.60 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.6
1ABBV.MI Yearly Current Assets VS Current Liabilites1ABBV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. 1ABBV.MI Growth Analysis

3.1 Past

  • The earnings per share for 1ABBV have decreased by -1.19% in the last year.
  • The Earnings Per Share has been decreasing by -0.99% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.29% on average over the next years. This is quite good.
  • 1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.29%
Revenue Next Year9.84%
Revenue Next 2Y8.84%
Revenue Next 3Y7.94%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1ABBV.MI Yearly Revenue VS Estimates1ABBV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
1ABBV.MI Yearly EPS VS Estimates1ABBV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1ABBV.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.01, 1ABBV is valued on the expensive side.
  • 1ABBV's Price/Earnings ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 82.50% of the companies in the same industry.
  • 1ABBV's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.58.
  • The Price/Forward Earnings ratio is 14.47, which indicates a correct valuation of 1ABBV.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 93.75% of the companies listed in the same industry.
  • 1ABBV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 21.01
Fwd PE 14.47
1ABBV.MI Price Earnings VS Forward Price Earnings1ABBV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 1ABBV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1ABBV is cheaper than 80.00% of the companies in the same industry.
  • 1ABBV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 88.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.87
EV/EBITDA 15.4
1ABBV.MI Per share data1ABBV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1ABBV's earnings are expected to grow with 21.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3Y21.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1ABBV.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.16%, 1ABBV has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.67, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 96.25% of the companies listed in the same industry.
  • 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

  • On average, the dividend of 1ABBV grows each year by 7.72%, which is quite nice.
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1ABBV pays out 489.69% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP489.69%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
1ABBV.MI Yearly Income VS Free CF VS Dividend1ABBV.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1ABBV.MI Dividend Payout.1ABBV.MI Dividend Payout, showing the Payout Ratio.1ABBV.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ABBV.MI Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

BIT:1ABBV (3/27/2026, 7:00:00 PM)

182.8

+7.2 (+4.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-23
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap323.08B
Revenue(TTM)N/A
Net Income(TTM)2.35B
Analysts78.38
Price Target214.66 (17.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly Dividend5.29
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)0.56%
PT rev (3m)8.51%
EPS NQ rev (1m)-20.87%
EPS NQ rev (3m)-20.2%
EPS NY rev (1m)-6.62%
EPS NY rev (3m)-5.66%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 21.01
Fwd PE 14.47
P/S 6.23
P/FCF 18.87
P/OCF 17.81
P/B N/A
P/tB N/A
EV/EBITDA 15.4
EPS(TTM)8.7
EY4.76%
EPS(NY)12.63
Fwd EY6.91%
FCF(TTM)9.69
FCFY5.3%
OCF(TTM)10.27
OCFY5.62%
SpS29.35
BVpS-1.3
TBVpS-45.56
PEG (NY)0.46
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROCE 20.86%
ROIC 15.64%
ROICexc 16.59%
ROICexgc 572.43%
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
FCFM 33%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Debt/EBITDA 2.39
Cap/Depr 14.25%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 74.59%
Profit Quality 838.33%
Current Ratio 0.72
Quick Ratio 0.6
Altman-Z 2.32
F-Score7
WACC8.96%
ROIC/WACC1.75
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.04%
Revenue Next Year9.84%
Revenue Next 2Y8.84%
Revenue Next 3Y7.94%
Revenue Next 5Y6.02%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year-0.19%
EBIT Next 3Y15.91%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%

ABBVIE INC / 1ABBV.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 4 / 10 to 1ABBV.MI.


What is the valuation status for 1ABBV stock?

ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.


How profitable is ABBVIE INC (1ABBV.MI) stock?

ABBVIE INC (1ABBV.MI) has a profitability rating of 5 / 10.


What is the financial health of ABBVIE INC (1ABBV.MI) stock?

The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.


What is the expected EPS growth for ABBVIE INC (1ABBV.MI) stock?

The Earnings per Share (EPS) of ABBVIE INC (1ABBV.MI) is expected to grow by 45.22% in the next year.